肠道菌群与骨关节疾病的关系及中医药调节研究进展

被引:13
作者
李辉 [1 ]
谢兴文 [2 ]
李宁 [1 ]
李建国 [2 ]
李鼎鹏 [2 ]
丁聚贤 [2 ]
柳博 [2 ]
罗鹏飞 [1 ]
机构
[1] 甘肃中医药大学
[2] 甘肃省第二人民医院西北民族大学附属医院
关键词
肠道菌群; 中医药; 骨质疏松; 骨关节炎; 类风湿; 痛风;
D O I
暂无
中图分类号
R274.9 [现代医学骨伤科疾病];
学科分类号
100210 [外科学];
摘要
肠道菌群是人体内最大的微生物库,由一千多种不同的物种组成,其结构和代谢产物随宿主年龄、饮食结构及肠道环境的变化而发生动态变化。研究表明,肠道微生物在调节人类众多生理病理过程中发挥关键作用,并且已被证明肠道菌群失衡可能是影响骨关节疾病发生发展的关键因素,这其中包括骨质疏松、骨关节炎、类风湿性关节炎、痛风性关节炎等几种常见的骨关节疾病。目前临床多使用降钙素、雌激素、非甾体抗炎药、免疫抑制剂、黄嘌呤氧化酶抑制剂等西药治疗上述相关骨关节疾病,但长期服用患者依从性差,胃肠道不良反应明显。中医药治疗骨关节疾病以其价廉、效优、不良反应小等占据重要治疗地位,并且具有多靶点、多机制、多层次的作用优势。近年来众多学者基于中医学肝肾理论,运用大量“补肝肾”“强筋骨”类中药治疗骨关节疾病进行了大量实验及临床研究,取得了可喜成果,但其作用机制尚未完全阐明。肠道菌群作为近年来医学研究领域的热点之一。研究发现,肠道菌群与骨关节疾病之间的关系密切。该文通过查阅国内外相关文献,发现中医药通过调节肠道菌群治疗骨关节疾病疗效显著,并且相关研究十分广泛。因此,笔者将近年来发表的相关文献进行整理,就肠道菌群与骨关节疾病的关系及中药活性成分和中药复方干预肠道菌群的研究进展做一综述,以期为中医药防治骨与关节疾病提供参考和依据。
引用
收藏
页码:268 / 275
页数:8
相关论文
共 66 条
[21]
Fermentation of Pleurotus ostreatus and Ganoderma lucidum mushrooms and their extracts by the gut microbiota of healthy and osteopenic women: potential prebiotic effect and impact of mushroom fermentation products on human osteoblasts.[J] Kerezoudi Evangelia N;Mitsou Evdokia K;Gioti Katerina;Terzi Eirini;Avgousti Ifigeneia;Panagiotou Alexandra;Koutrotsios Georgios;Zervakis Georgios I;Mountzouris Konstantinos C;Tenta Roxane;Kyriacou Adamantini Food & function 2021,
[22]
Effect of a Traditional Chinese Medicine Formula (CoTOL) on Serum Uric Acid and Intestinal Flora in Obese Hyperuricemic Mice Inoculated with Intestinal Bacteria[J] Gao Yan;Sun Jing;Zhang Yi;Shao Tiejuan;Li Haichang;Wang Meijiao;Zhang Li;Bian Hua;Wen Chengping;Xie Zhijun;Lv Huiqing Evidence-Based Complementary and Alternative Medicine 2020,
[23]
Mycotoxin and Gut Microbiota Interactions.[J] Guerre Philippe Toxins 2020,
[24]
Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity[J] Li Bo;Liu Mingyan;Wang Yu;Gong Shiqiang;Yao Weifan;Li Wenshuai;Gao Hua;Wei Minjie Biomedicine & Pharmacotherapy 2020,
[25]
Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats[J] Chen Xue;Ge Hong-Zhang;Lei Shan-Shan;Jiang Ze-Tian;Su Jie;He Xinglishang;Zheng Xiang;Wang Hui-Ying;Yu Qiao-Xian;Li Bo;Lv Gui-Yuan;Chen Su-Hong Biomedicine & Pharmacotherapy 2020,
[26]
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis.[J] Jiang Yuhe;Zhang Ping;Zhang Xiao;Lv Longwei;Zhou Yongsheng Cell proliferation 2020,
[27]
The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia.[J] Liu Xiu;Lv Qiulan;Ren Hongyan;Gao Liu;Zhao Peng;Yang Xiaomin;Yang Guanpin;Xu Daxing;Wang Guangtao;Yang Wan;Wang Pengjun;Wang Zenglan;Xing Shichao PeerJ 2020,
[28]
Recent advances in bone-targeted therapy[J] Chen Shi;Tingting Wu;Yu He;Yu Zhang;Dehao Fu Pharmacology and Therapeutics 2020,
[29]
Chicory ameliorates hyperuricemia via modulating gut microbiota and alleviating LPS/TLR4 axis in quail[J] Meng Bian;Juan Wang;Yu Wang;Anzheng Nie;Chunsheng Zhu;Zongxi Sun;Zheng Zhou;Bing Zhang Biomedicine & Pharmacotherapy 2020,
[30]
The microbiome and rheumatoid arthritis[J] Anne-Sophie Bergot;Rabina Giri;Ranjeny Thomas Best Practice & Research Clinical Rheumatology 2019,